- Record: found
- Abstract: found
- Article: not found
Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients.
Fumitaka Suzuki
1 ,
Yoshiyuki Suzuki ,
Hitomi Sezaki ,
Norio Akuta ,
Yuya Seko ,
Yusuke Kawamura ,
Tetsuya Hosaka ,
Masahiro Kobayashi ,
Satoshi Saito ,
Yasuji Arase ,
Kenji Ikeda ,
Rie Mineta ,
Sachiyo Watahiki ,
Mariko Kobayashi ,
Yoshiyuki Nakayasu ,
Hidetaka Tsuda ,
Keiji Aoki ,
Ichimaro Yamada ,
Hiromitsu Kumada
Jul 2013
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aims of this study are to assess the antiviral effects, safety and telaprevir (TVR) pharmacokinetics in two cohorts given TVR every 8 h (q8h) at doses of 500 mg and 750 mg with peginterferon-α-2b and ribavirin in chronic hepatitis C patients.